Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cerilliant
Johnson and Johnson
UBS
Fish and Richardson
McKinsey
AstraZeneca
Deloitte
Farmers Insurance

Generated: June 21, 2018

DrugPatentWatch Database Preview

DARVON COMPOUND Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Darvon Compound patents expire, and when can generic versions of Darvon Compound launch?

Darvon Compound is a drug marketed by Xanodyne Pharm and is included in one NDA.

The generic ingredient in DARVON COMPOUND is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.
Summary for DARVON COMPOUND
Drug patent expirations by year for DARVON COMPOUND

US Patents and Regulatory Information for DARVON COMPOUND

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xanodyne Pharm DARVON COMPOUND aspirin; caffeine; propoxyphene hydrochloride CAPSULE;ORAL 010996-006 Mar 8, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Xanodyne Pharm DARVON COMPOUND-65 aspirin; caffeine; propoxyphene hydrochloride CAPSULE;ORAL 010996-007 Mar 8, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Queensland Health
Julphar
AstraZeneca
Accenture
US Department of Justice
McKesson
Moodys
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.